University of Bristol: Interleukin-6 Antagonists Improve Outcomes in Hospitalized COVID-19 Patients
July 08, 2021
July 08, 2021
BRISTOL, England, July 8 (TNSJou) (TNSRep) -- The University of Bristol issued the following news release on July 6, 2021:
Findings from a study published today [6 July] in the Journal of the American Medical Association (JAMA) have prompted new World Health Organization (WHO) recommendations to use interleukin-6 antagonists in patients with severe or critical COVID-19 along with corticosteroids.
A new analysis of 27 randomized trials involving nearly 11,000 patients fo . . .
Findings from a study published today [6 July] in the Journal of the American Medical Association (JAMA) have prompted new World Health Organization (WHO) recommendations to use interleukin-6 antagonists in patients with severe or critical COVID-19 along with corticosteroids.
A new analysis of 27 randomized trials involving nearly 11,000 patients fo . . .